Akari Therapeutics, Plc

(NASDAQ) AKTX

Current Price$17.69

Market Cap$232.68M

Since IPO (2015)-100%

5 Year-100%

1 Year-90%

1 Month-12%

Akari Therapeutics, Plc Financials at a Glance

Market Cap

$232.68M

Revenue (TTM)

$0.00

Net Income (TTM)

$28.05M

EPS (TTM)

$-18.86

P/E Ratio

-0.02

Dividend

$0.00

Beta (Volatility)

0.53 (Low)

Dividend

$0.00

Beta (Volatility)

0.53 (Low)

Price

$17.69

Volume

33,982,124

Open

$9.92

Price

$17.69

Volume

33,982,124

Open

$9.92

Previous Close

$18.27

Daily Range

$8.58 - $18.99

52-Week Range

$3.02 - $56.80

Dividend

$0.00

Beta (Volatility)

0.53 (Low)

Price

$17.69

Volume

33,982,124

Open

$9.92

Previous Close

$18.27

Daily Range

$8.58 - $18.99

52-Week Range

$3.02 - $56.80

AKTX News

arrow pointing up and down with question mark

Is This Why Akari Therapetuics PLC Is Falling Today?

Brian FeroldiApr 24, 2017

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Akari Therapeutics, Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Abizer Gaslightwala, MBA

Website

www.akaritx.com

Headquarters

London, FL W1G 9RT, GB

AKTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-155%

Return on Capital

-1%

Return on Assets

-83%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$232.68M

Shares Outstanding

45.27M

Volume

33.98M

Avg. Volume

133.54K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$17.27M

EBITDA

$17.35M

Operating Cash Flow

$10.57M

Capital Expenditure

$0.00

Free Cash Flow

$10.57M

Cash & ST Invst.

$5.20M

Total Debt

$754.00K

Akari Therapeutics, Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$232.68M

N/A

Market Cap/Employee

$29.08M

N/A

Employees

N/A

Net Income

$14.46M

-290.1%

EBITDA

$15.25M

-317.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$2.04M

+176.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$732.00K

-60.3%

Return on Assets

-82.76%

N/A

Return on Invested Capital

-1.44%

N/A

Free Cash Flow

$2.49M

-15.7%

Operating Cash Flow

$2.49M

-15.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CDTCDT Equity Inc.

CDTCDT Equity Inc.$1.05-13.93%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.07-0.93%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.26+1.61%

XAGELongevity Health Holdings Inc.

XAGELongevity Health Holdings Inc.$0.30-6.28%

PPBTPurple Biotech Ltd.

PPBTPurple Biotech Ltd.$2.88+6.67%

MSPRMSP Recovery, Inc.

MSPRMSP Recovery, Inc.$0.03-7.67%

PBMPsyence Biomedical Ltd.

PBMPsyence Biomedical Ltd.$4.10+0.99%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.84+0.01%

Questions About AKTX

What is the current price of Akari Therapeutics, Plc?

Akari Therapeutics, Plc is trading at $18.27 per share.

What is the 52-week range for Akari Therapeutics, Plc?

Over the past 52 weeks, Akari Therapeutics, Plc has traded between $3.02 and $56.80.

How much debt does Akari Therapeutics, Plc have?

As of the most recent reporting period, Akari Therapeutics, Plc reported total debt of $732,000.

How much cash does Akari Therapeutics, Plc have on hand?

Akari Therapeutics, Plc reported $2.83M in cash and cash equivalents in its most recent financial results.

What is Akari Therapeutics, Plc’s dividend yield?

Akari Therapeutics, Plc does not currently have a dividend yield.

Akari Therapeutics, Plc

Akari Therapeutics, Plc Financials at a Glance

AKTX News

Is This Why Akari Therapetuics PLC Is Falling Today?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Akari Therapeutics, Plc

AKTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Akari Therapeutics, Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AKTX

What is the current price of Akari Therapeutics, Plc?

What is the 52-week range for Akari Therapeutics, Plc?

How much debt does Akari Therapeutics, Plc have?

How much cash does Akari Therapeutics, Plc have on hand?

What is Akari Therapeutics, Plc’s dividend yield?

Premium Investing Services